These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14095405)

  • 21. The action of tyrosinase on thrombin, fibrinogen, and fibrin.
    SIZER IW; WAGLEY PF
    J Biol Chem; 1951 Sep; 192(1):213-21. PubMed ID: 14917667
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 23. The clotting of the blood of an amphibian, Bufo marinus Linn. 1. Prothrombin-thrombin and "fibrinogen-fibrin" stages.
    HACKETT E; LEPAGE R
    Aust J Exp Biol Med Sci; 1961 Feb; 39():57-65. PubMed ID: 13710284
    [No Abstract]   [Full Text] [Related]  

  • 24. [Possibility of immunochemical study of fibrinolysis].
    Seligmann M
    Rev Fr Etud Clin Biol; 1958 Dec; 3(10):1073-5. PubMed ID: 13624299
    [No Abstract]   [Full Text] [Related]  

  • 25. BLOOD COAGULATION: PRACTICAL SIGNIFICANCE OF RECENT ADVANCES IN KNOWLEDGE OF PROTHROMBIN.
    SEEGERS WH
    Tex State J Med; 1963 Nov; 59():1068-75. PubMed ID: 14084901
    [No Abstract]   [Full Text] [Related]  

  • 26. ACCELERATION OF FIBRIN POLYMERIZATION BY ACETATE AND OTHER LOW MOLECULAR IONS.
    ABILDGAARD U
    Scand J Clin Lab Invest; 1964; 16():521-30. PubMed ID: 14209212
    [No Abstract]   [Full Text] [Related]  

  • 27. [SHORT SURVEY ON RESEARCH LEADING TO A CLARIFICATION OF HEMOPHILIA].
    KUKOWKA A
    Z Gesamte Inn Med; 1963 Aug; 18():730-8. PubMed ID: 14083669
    [No Abstract]   [Full Text] [Related]  

  • 28. [EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE].
    HIRATA T
    Kobe Ika Daigaku Kiyo; 1963 Dec; 25():1-9. PubMed ID: 14117791
    [No Abstract]   [Full Text] [Related]  

  • 29. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 30. [THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS].
    SAMAMA M
    Transfusion (Paris); 1964; 7():99-125. PubMed ID: 14168287
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 32. The interaction of protamine with human fibrinogen and the significance of this interaction for the coagulation of fibrinogen.
    GODAL HC
    Scand J Clin Lab Invest; 1960; 12(4):433-45. PubMed ID: 13706168
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Specificity and sensitivity of paracoagulation tests].
    Litvinov RI; Voronina IE; Gabitov SE
    Lab Delo; 1980; (11):662-6. PubMed ID: 6160297
    [No Abstract]   [Full Text] [Related]  

  • 36. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology.
    Lipinski B; Wegrzynowicz Z; Budzynski AZ; Kopeć M; Latallo ZS; Kowalski E
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):65-77. PubMed ID: 5584961
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of heparin and protamine on fibrinogen precipitation].
    TARNOKY K
    Kiserl Orvostud; 1961 Dec; 13():633-40. PubMed ID: 13919689
    [No Abstract]   [Full Text] [Related]  

  • 38. [Products of the lysis of circulating fibrinogen in various pathological conditions. Immunochemical study].
    FERRI RG; FERREIRA HC
    Rev Hosp Clin Fac Med Sao Paulo; 1961; 16():406-9. PubMed ID: 13892573
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 40. The fibrinogen molecule: its size, shape, and mode of polymerization.
    HALL CE; SLAYTER HS
    J Biophys Biochem Cytol; 1959 Jan; 5(1):11-6. PubMed ID: 13630928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.